alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



Exhibit 31.2 CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Timothy A. Larkin, certify that:  1.
    
    I have reviewed this Amendment No. 2 to the Quarterly Report on Form 10-Q of Warren
Resources, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officers and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:  (a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in
which this report is being prepared;(b)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report
based on such evaluation; and(c)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
that has materially affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting;  5.
    
    The registrants other certifying officers and I have disclosed, based on our most recent
evaluation of internal control over the financial reporting, to the registrants auditors and
the audit committee of registrants board of directors:  (a)
    
    All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting. /s/ Timothy A. LarkinTimothy A. Larkin,Executive Vice President and Chief Financial Officer
 December 7, 2004 A signed original of this original statement required by Section 302 has been provided to Warren
Resources, Inc., and will be retained by Warren Resources, Inc. and furnished to the Securities and
Exchange Commission or its staff 4
NAC Aeronautics Committee Public FINAL Agenda

November 14-15, 2016

NASA Ames Research Center

Moffett Field, CA

NASA Ames Conference Center, Building 3

Monday, November 14 (Sessions are public except as noted)

2:00 PM to 2:15 PM Welcome and announcements

2:15 PM to 3:00 PM Ames Research Center Welcome/Ames Aeronautics 

Overview

3:00 PM - 4:00 PM CFD Vision 2030 Implementation Plan

4:00 PM - 4:15 PM Break

4:15 PM - 5:15 PM New Funding Model for Key Facilities

5:15 - 5:45 PM Committee Deliberations

5:45 - 6:00 PM Public Comment Period

6:00 PM Adjourn

Tuesday, November 15 (Sessions are public except as noted)

9:45 AM to 10:00 AM Welcome and announcements

10:00 AM - 10:45 AM Vision & Strategic Planning for Advanced Aviation 

Operations (Thrusts 1, 5 & 6)

10:45 AM to 11:45 AM Real Time System Wide Safety Roadmap and Project 

Planning

11:45 AM to 12:45 PM Lunch (non-public)

12:45 PM to 1:45 PM Autonomy Roadmap and Project Planning

1:45 PM to 2:15 PM 2017 Work Plan & Schedule Discussion

2:15 PM to 2:45 PM Committee Deliberations

2:45 PM to 3:00 PM Public Comment Period

3:00 PM Adjourn
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,

Plaintiff

- Appellee,

v.

OSCAR JAMES MITCHELL,

Defendant

- Appellant. No. 18

- 10058

D.C. No. 3:05

- cr

- 00233

- LRH

MEMORANDUM *

Appeal from the United States District Court

for the District of Nevada

Larry R. Hicks, District Judge, Presiding

Submitted November 27, 2018 **

Before: CANBY, TASHIMA, and FRIEDLAND, Circuit Judges.

Oscar James Mitchell appeals from the revocation of supervised release and

the 14

- month sentence imposed upon revocation. Pursuant to Anders v. California

,

386 U.S. 738 (1967), Mitchell ’s counsel has filed a brief stating that there are no

grounds for relief, along with a motion to withdraw as counsel o f record. We have

* This disposition is not appropriate for publication and is not precedent

except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

DEC 3 2018

MOLLY C. DWYER, CLER K

U.S. COURT O F APPEALS2 18

- 10058

provided Mitchell the opportunity to file a pro se supplemental brief. No pro se

supplemental brief or answering brief has been filed.

Our independent review of the record pursuant to Penson v. Ohio , 488 U.S.

75, 80 (1988), discloses no arguable grounds for relief on direct appeal.

Counsel’s motion to withdraw is GRANTED.

AFFIRMED.
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 22

- 6105

DANIEL DRAPER , Plaintiff

- Appellant ,

v. MS. BARNES, Warden; DR. ONAHA, Medical Doctor; MRS. RAMSEY, Medical Nurse , Defendants

- Appellees

.

Appeal from the United States District Court for the District of South Carolina , at Beaufort

. Timothy M. Cain , District Judge. ( 9:21

- cv - 00185

- TMC )

Submitted : April 14, 2022 Decided: April 19, 2022

Before DIAZ and RUSHING , Circuit Judges , and KEENAN, Senior Circuit Judge

.

Vacated and remanded by un published per curiam opinion

.
Daniel Draper, Appellant Pro Se. Beth Drake, Acting United States Attorney, OFFICE OF THE UNITED STATES ATTORNEY, Columbia, South Carolina, for Appellees.

Unpublished opinions are not binding precedent in this circuit. USCA4 Appeal: 22-6105 Doc: 17 Filed: 04/19/2022 Pg: 1 of 32 PER CURIAM: Daniel Draper appeals the district court’s order dismissing without prejudice hi s
action filed under Bivens v. Six Unknown Named Agents of Fed

. Bureau of Narcotics , 403 U.S. 388 (1971) , for failure to exhaust administrative remedies

. The district court referred this case to a magistrate judge pursuant to 28 U.S.C. § 636(b)(1)(B). The magistrate judge recommended dismiss ing the complaint and advised Draper that failure to file timely, specific objections to this recommendation could waive appellate review of a district court order based upon the recommendation. Draper did not file objections, and the district court accepted the magistrate judge’s recommendation to dismiss the complaint.
The district court subsequently issued a text order stating that it received notification that the magistrate judge’s report and recommendation was mistakenly mailed to the incorrect

person and correctional facility. All parties must be served with and given an opportunity to object to the findings and recommendations of a magistrate judge. 28 U.S.C. § 636(b)(1)(C). Here, the record
establishes t hat Draper did not receive the magistrate judge’s report and recommendation before the district court issued its dismissal order, thus depriving Draper of his right to file objections. Accordingly, we vacate the district court’s dismissal order ; grant Draper’s
motion to remand the case to the district court ; and remand with instructions to serve the magistrate judge’s report and recommendation on Draper and to provide him with an USCA4 Appeal: 22-6105 Doc: 17 Filed: 04/19/2022 Pg: 2 of 33 opportunity to file objections. ∗ We deny Draper’s motions to appoint counse l and to send an investigator to FCI Bennettsville . We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.
VACATED AND REMANDED

∗ Defendants do not oppose Draper’s motion to remand the case to the district court to allow Draper the opportunity to file objections to the magistrate judge’s report and recommendation. USCA4 Appeal: 22-6105 Doc: 17 Filed: 04/19/2022 Pg: 3 of 3
Aeronautics Research Mission Directorate 

X-Plane Sudoku

Complete the sudoku puzzles below. Each row, column, and 3x2 block must contain each of the 6 

letters in X PLANE.

1.

X P L A N E

X

L E A

N

A

E L N

2.

P E

X E A N

E X

N P

P N X

X A

3.

L E X

E

X P

P N

A

A L E

4.

X N

L

L

A N

P N A

E P

5.

N L

A

P

X N P

P

A E L

6.

A

E

L N

E X

A X

L
What are X-planes? NASA engineers partner with industry and other organizations to develop 

new aviation technologies that make air travel safer, more efficient, faster, and more 

environmentally friendly. To test these technologies, experimental aircraft, or X-planes, are built.

The first X-plane was flown in 1947 to demonstrate the ability to fly supersonic (faster than the 

speed of sound). Since then, NASA has collaborated on X-planes to test different wing shapes, 

different propulsion systems, and more. New X-planes continue to be built today as NASA 

aeronautics helps to shape the future of flight.
Answer Key
Aeronautics Research Mission Directorate 

X-Plane Sudoku

Complete the sudoku puzzles below. Each row, column, and 3x2 block must contain each of the 6 

letters in X PLANE.

1.

X P L A N E

N A E X L P

P L X N E A

A E N P X L

L N P E A X

E X A L P N

2.

P A N X L E

L X E A P N

E P A L N X

N L X E A P

A E P N X L

X N L P E A

3.

L A N E P X

P E X N L A

X N P A E L

E L A P X N

N X E L A P

A P L X N E

4.

X N E A L P

P A L N X E

N E P L A X

A L X E P N

L P N X E A

E X A P N L

5.

A N X P L E

E P L X A N

P E N A X L

X L A E N P

L X P N E A

N A E L P X

6.

E P X N L A

N A L E P X

X L P A N E

A E N L X P

P N A X E L

L X E P A N
What are X-planes? NASA engineers partner with industry and other organizations to develop 

new aviation technologies that make air travel safer, more efficient, faster, and more 

environmentally friendly. To test these technologies, experimental aircraft, or X-planes, are built.

The first X-plane was flown in 1947 to demonstrate the ability to fly supersonic (faster than the 

speed of sound). Since then, NASA has collaborated on X-planes to test different wing shapes, 

different propulsion systems, and more. New X-planes continue to be built today as NASA 

aeronautics helps to shape the future of flight.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Science Foundation

# ACTION:

Change in Notice of Meeting.

# SUMMARY:

                        The National Science Foundation published a Notice of Meeting in the                         **Federal Register**                         on Monday, October 25, page 65528. The topics listed in the agenda have been changed.                    

*Date/Time:*                         November 16, 2010; 1 p.m. to 5:30 p.m. (EST).                    

November 17, 2010; 8 a.m. to 12 p.m. (EST).

*Place:*                         Arlington Hilton, Gallery II Conference Room, Arlington, VA.                    

*Type of Meeting:*                         OPEN.                    

*Contact Person:*                         Patty Balanga, National Science Foundation, 4201 Wilson Boulevard, Arlington, VA 22230, (703) 292-8100.                    

*Purpose of Meeting:*                         To provide advice concerning issues related to the oversight, integrity, development and enhancement of NSF's business operations.                    

## Agenda

### November 16, 2010

Welcome/Introductions; BFA Update; The Changing Workplace: Challenges in a Federal Context (Overview and Panel Discussion); Committee Discussion: Prepare for Meeting with NSF Deputy Director; Discussion with Deputy Director; Open Government.

### November 17, 2010

The Changing Workplace: Challenges in a Federal Context (Discussion Continued); International Facilities Subcommittee; Committee Expectations/Closing Discussions.

Dated: October 29, 2010.

Susanne Bolton,

Committee Management Officer.

[FR Doc. 2010-27791 Filed 11-3-10; 8:45 am]

BILLING CODE 7555-01-P
**Exhibit
      32.1**








**CERTIFICATON
      OF CHIEF EXECUTIVE OFFICER**





**Pursuant
      to 18 U.S.C. § 1350, as adopted pursuant to**


**§
      906 of the Sarbanes-Oxley Act of 2002**





In
      connection with the filing with the Securities and Exchange Commission of the
      Quarterly Report of Hemagen Diagnostics, Inc. on Form 10-QSB for the period
      ending June 30, 2007, (the ”Report”), I, William P. Hales, certify, pursuant to
      18 U.S.C. § 1350, that:





(1)
            The
                Report fully complies with the requirements of section 13(a) or 15(d)
                of    the Securities Exchange Act of 1934;
                and





(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company.














/s/
      William P.
      Hales


William
      P. Hales


President
      and Chief Executive Officer


(Principal
      Executive Officer)














August
      13, 2007





























A
      signed
      original of this written statement required by Section 906 has been provided
      to
      Hemagen Diagnostics, Inc. and  will be retained by Hemagen
      Diagnostics, Inc.  and furnished to the Securities and Exchange
      Commission or its staff upon request.
10:30 AM to 10:45 AM Welcome and Announcements Ms. Marion Blakey, Committee Chair 

and Irma Rodriguez, Committee 

Executive Secretary

10:45 AM to 11:00 AM Welcome to NASA Langley Research 

Center (LaRC)

Mr. Dana Gould, Deputy Director, LaRC 

Aeronautics Research

11:00 AM to 12:00 PM Aeronautics Research Mission 

Directorate (ARMD) FY18 Budget

Mr. Robert Pearce, Deputy Associate 

Administrator for ARMD

12:00 PM to 1:00 PM Lunch (non-public) All

1:00 PM to 2:00 PM New Aviation Horizons (NAH) Planning 

and Management Status

Dr. Ed Waggoner, Director, Integrated 

Aviation Systems Program (IASP)

2:00 PM to 3:00 PM University Leadership Initiative (ULI) Mr. Richard Barhydt, Deputy Director, 

Transformative Aeronautics Concepts 

Program (TACP)

3:00 PM to 3:15 PM Break All

3:15 PM to 4:15 PM Airspace Technology Demonstration 

(ATD) Overview

Mr. Akbar Sultan, Deputy Director, 

Airspace Operations and Systems 

Program (AOSP)

4:15 PM to 5:00 PM Committee Deliberations All

5:00 PM to 5:15 PM Public Comment Period Ms. Marion Blakey, Committee Chair

5:30 PM Adjourn

To Join the Meeting Remotely:

https://nasa.webex.com/ Meeting number: 996 745 754 

Meeting password: CFKxfq@3

Join by phone 1-844-467-6272

Passcode: 208191 

Need help? Go to http://help.webex.com. 

100 Exploration Way

Hampton, VA 23666

Tuesday, July 25 (Sessions are public except as noted)

NAC Aeronautics Committee Public FINAL Agenda

July 25, 2016

National Institute of Aerospace

Room 141
National Aeronautics and 

Space Administration

Mary W. Jackson Building NASA Headquarters

Washington, DC 20546-0001

March 28, 2022 

Reply to Attn of: General Law Practice Group

TO: Distribution

FROM: Agency Counsel for Ethics 

SUBJECT: Determination Regarding Attendance by NASA employees at the Heinrich 

Boell Foundation Dinner on March 30, 2022 

On March 30, 2022, the Heinrich Boell Foundation (the Foundation), a nonprofit organization 

under 501(c)(3) of the Internal Revenue Code, will host a dinner at the Tabbard Inn in 

Washington, DC, starting at 6:45 p.m. The event provides an opportunity for informal 

discussion on how to shape inclusive and sustainable technology innovation ecosystems. 

Approximately 15 people have been invited to attend. Attendees will have a diversity of 

views or interests and will include representatives from foreign government, industry, and 

employees of Federal agencies. The estimated cost of the event, including all food and 

beverages, is $130 per person. The Foundation is in control of the organizing, planning and 

invitations for this event. Attendance at this event will allow NASA attendees to exchange 

information regarding various NASA programs. I find that the event meets the requirements 

of a “widely attended gathering” as defined in 5 C.F.R. § 2635.204(g)(2). 

I further determine that there is an Agency interest in having NASA personnel attend the 

event because it will provide an opportunity for the invited persons to exchange ideas and 

views pertaining to NASA’s policies, programs and operations. NASA employees, including 

NASA employees in non-career positions who are required to sign the ethics pledge under 

Executive Order 13989, who do not have a significant role in a matter affecting the interests 

of the Foundation may accept an invitation for free attendance to the event. In those 

circumstances, I find that the Agency’s interest in attendance outweighs any concern that the 

individual may be, or may appear to be, improperly influenced in the performance of their 

duties. 

However, NASA employees who have a significant role in any pending matter affecting the 

interests of the Foundation, such as procurement duties, program management, or negotiating 

or administering a Space Act Agreement, should seek a separate determination from their 

local ethics counselor as to whether they may accept the invitation. Attendees are reminded 

to exercise any COVID-19 precautions appropriate to their individual situation. 

Adam F. Greenstone
II 

108TH CONGRESS 

1ST SESSION S. 1694

To amend title 38, United States Code, to authorize the Secretary of Veterans 

Affairs to provide veterans who participated in certain Department of 

Defense chemical and biological warfare testing to be provided health 

care for illness without requirement for proof of service-connection. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 1, 2003

Mr. BROWNBACK introduced the following bill; which was read twice and 

referred to the Committee on Veterans’ Affairs 

A BILL

To amend title 38, United States Code, to authorize the 

Secretary of Veterans Affairs to provide veterans who 

participated in certain Department of Defense chemical 

and biological warfare testing to be provided health care 

for illness without requirement for proof of service-connection.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Health Care for Vet5 erans of Project 112/Project SHAD Act of 2003’’. 
2

•S 1694 IS 

1 SEC. 2. PROVISION OF HEALTH CARE TO VETERANS WHO 

2 PARTICIPATED IN CERTAIN DEPARTMENT OF 

3 DEFENSE CHEMICAL AND BIOLOGICAL WAR4 FARE TESTING. 

5 Section 1710(e) of title 38, United States Code, is 

6 amended—

7 (1) in paragraph (1), by adding at the end the 

8 following new subparagraph: 

9 ‘‘(E) Subject to paragraphs (2) and (3), a veteran 

10 who participated in a test conducted by the Department 

11 of Defense Deseret Test Center as part of a program for 

12 chemical and biological warfare testing from 1962 through 

13 1973 (including the program designated as ‘Project Ship14 board Hazard and Defense (SHAD)’ and related land15 based tests) is eligible for hospital care, medical services, 

16 and nursing home care under subsection (a)(2)(F) for any 

17 illness, notwithstanding that there is insufficient medical 

18 evidence to conclude that such illness is attributable to 

19 such testing.’’; 

20 (2) in paragraph (2)(B), by striking ‘‘para21 graph (1)(C) or (1)(D)’’ and inserting ‘‘subpara22 graph (C), (D), or (E) of paragraph (1)’’; and 

23 (3) in paragraph (3)—

24 (A) by striking ‘‘and’’ at the end of sub25 paragraph (B); 
3

•S 1694 IS 

1 (B) by striking the period at the end of 

2 subparagraph (C) and inserting ‘‘; and’’; and 

3 (C) by adding at the end the following new 

4 subparagraph: 

5 ‘‘(D) in the case of care for a veteran described 

6 in paragraph (1)(E), after December 31, 2005.’’.

Æ